Advertisement

Topics

FDA OKs Merk Drug That Prevents Infection Post-Stem Cell Transplant

10:35 EST 10 Nov 2017 | Bioethics.com

(Reuters) – Merck & Co Ltd’s drug to prevent serious infection in patients who undergo a type of stem cell transplant was approved by the U.S. Food and Drug Administration, the drugmaker said on Thursday.  Merck said the drug, which … Read More

Original Article: FDA OKs Merk Drug That Prevents Infection Post-Stem Cell Transplant

NEXT ARTICLE

More From BioPortfolio on "FDA OKs Merk Drug That Prevents Infection Post-Stem Cell Transplant"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...